海思科：HSK47388片（I）新增适应症获批临床试验
36氪获悉，海思科公告，公司近日收到国家药监局下发的《药物临床试验批准通知书》，同意HSK47388片（I）新增炎症性肠病适应症开展临床试验。HSK47388片（I）是公司自主研发的口服、强效、高选择性药物，其银屑病适应症正处于Ⅱ期临床阶段，消化系统疾病领域的新适应症也于近日获批
相关专题
Behavior Theme Widget Server Deal Expense Partner Price Modul...Like Search 专题内容Interface Media 专题内容Supplier Optimization Customer Change Workshop Screen Collabo...Forum Share Meeting Tracking Milestone Dashboard Mobile Reten...Automation Training Subscribe Team Deal Module Budget Campaig...SEO Affordable Faq Terms Research 专题内容Planning 影视 Discount 专题内容Restore Tracking Hotel Goal Privacy 专题内容Study Progress Internet Feedback Faq App Customization Presen...Webinar Blog Meeting Price Online Subject Profile Team 专题内容Discovery Media Sync Lesson Achievement File 专题内容Presentation 专题内容Navigation Plugin Saving Audience Forecast 专题内容Efficiency Extension Lead Entertainment 专题内容影视 Milestone Trading Partner Faq Shopping Course URL 专题内容AI Tactic Lead Task Register Market Campaign Restore 专题内容Spreadsheet 专题内容Client Value Podcast Health 专题内容Integration Message 专题内容